|View printer-friendly version|
|BD To Present At Inaugural CECP CEO Investor Forum|
The presentation will focus on the importance of shared value and ESG (environmental, social, and governance) factors in our strategic plan for creating long-term value for stakeholders.
A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
About CECP: The CEO Force for Good
CECP is a CEO led coalition that believes that a company's social strategy — how it engages with key stakeholders including employees, communities, investors, and customers —determines company success. Founded in 1999 by actor and philanthropist
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bd-to-present-at-inaugural-cecp-ceo-investor-forum-300411100.html
SOURCE BD (